Neurotrophins and Proneurotrophins as Biomarkers for Overactive Bladder Syndrome in Aging Females
Metabolites · 23.06.2025 · 15 (7) · 429
DOI: 10.3390/metabo15070429 ↗Kurz gefasst
Fachartikel in der Zeitschrift Metabolites, online erschienen am 23.06.2025. Verfasst von Claudia Covarrubias und 2 weiteren Autor:innen. Beteiligte Einrichtung: Lady Davis Institute, McGill University, Montreal, QC H3T1E2, Canada. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Quebec Network for Research on Aging, Canadian Urological Association, Canadian Urological Association Scholarship Foundation Career Development Award.
Abstract (Originalsprache)
Background/Objectives: Overactive bladder (OAB), common in elderly women, involves urgency, frequency, and nocturia, with complex phenotypes. The use of neurotrophins as non-invasive urinary biomarkers has been previously explored. The objective of this study was to assess the diagnostic and therapeutic utility of urinary biomarkers in a Canadian population of aging female OAB patients.
Methods
We conducted a single-center prospective study of aging female patients diagnosed with OAB and age-matched healthy controls, where we conducted pre- and post-treatment assessments using a combination of clinical questionnaires, voiding diaries, and urinary biomarkers nerve growth factor (NGF), proform of NGF (proNGF), brain-derived neurotrophic factor (BDNF), proform of BDNF (proBDNF), and neurotrophin receptor p75 extracellular domain (p75ECD)) quantified using ELISA. Baseline and post-treatment urinary biomarker levels in OAB patients were compared with those of controls.
Results
OAB patients and controls at baseline displayed significant differences in neurotrophin levels and in their ratios of mature/precursors. In the post-treatment OAB cohort, only NGF and proNGF exhibited significant improvement correlating with clinical symptom relief. Biomarkers in non-responders remained unchanged, suggesting heterogeneity in therapeutic response.
Conclusions
Urinary neurotrophins show promise as non-invasive diagnostic markers of OAB and monitoring treatment response in aging female patients. While this study focused on patients broadly diagnosed with OAB, future research should aim to classify OAB subtypes—such as those based on urodynamic studies or underlying pathophysiology—to better understand how urinary neurotrophins can differentiate between mechanisms like detrusor overactivity, detrusor underactivity, or bladder outlet obstruction. This will enhance their relevance in guiding personalized treatment strategies and predicting outcomes.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Lady Davis Institute, McGill University, Montreal, QC H3T1E2, Canada.
- Urology Department, Jewish General Hospital, Montreal, QC H3T1E2, Canada.
ORCID-Profile: Claudia Covarrubias
Förderung
- Quebec Network for Research on Aging
- Canadian Urological Association
- Canadian Urological Association Scholarship Foundation Career Development Award
Zitieren
APA
Covarrubias, C., Cammisotto, P. G., & Campeau, L. (2025). Neurotrophins and Proneurotrophins as Biomarkers for Overactive Bladder Syndrome in Aging Females. Metabolites, 15(7), 429. https://doi.org/10.3390/metabo15070429
Vancouver
Covarrubias C, Cammisotto PG, Campeau L. Neurotrophins and Proneurotrophins as Biomarkers for Overactive Bladder Syndrome in Aging Females. Metabolites. 2025;15(7):429. doi:10.3390/metabo15070429
BibTeX
@article{Covarrubias2025,
author = {Covarrubias, Claudia and Cammisotto, Philippe G and Campeau, Lysanne},
title = {Neurotrophins and Proneurotrophins as Biomarkers for Overactive Bladder Syndrome in Aging Females},
journal = {Metabolites},
year = {2025},
volume = {15},
number = {7},
pages = {429},
doi = {10.3390/metabo15070429}
}
EUVIMED